Table 3. Comparison of perivascular FAI parameters with different study groups (TAK vs. control group, TAK-CAI vs. TAK-nonCAI, localised vs. diffuse groups, active vs. inactive inflammation groups).
| Parameters (HU) | Control group1
(n=51) |
TAK group2 (n=111) | TAK-nonCAI group3 (n=59) | TAK-CAI group4
(n=52) |
Diffused group5
(n=27) |
Localized group6
(n=25) |
Active inflammation group7 (n=33) | Inactive inflammation group8 (n=78) | P value | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1 vs. 2) | (1 vs. 3) | (4 vs. 3) | (5 vs. 6) | (7 vs. 8) | |||||||||
| FAI | −90 [−94, −86] |
−81 [−76, −74] |
−84 [−88, −77] |
−78 [−82.75, −69.75] |
−74.00 [−80.00, −66.00] |
−81 [−85.50, −75] |
−77.50 [−72, −66] |
−84 [−87, −79] | <0.001 | <0.001 | <0.001 | 0.005 | <0.001 |
| 10th percentile | −138 [−144, −131] |
−128 [−135, −115] |
−132 [−142, −119] |
−121 [−130, −106] |
−111.00 [−123.00, −100.00] |
−128 [−134, −116.50] |
−109 [−120.50, −100] |
−131.50 [−139.25, −123] | <0.001 | 0.005 | <0.001 | 0.003 | <0.001 |
| 90th percentile | −43 [−47, −42] |
−39 [−41, −38] |
−40 [−41.10, −38] |
−39 [−41, −37] |
−38.00 [−40.00, −37.00] |
−39 [−42, −38] |
−38 [−38.50, −36.50] |
−40 [−42, −39] |
<0.001 | <0.001 | 0.020 | 0.023 | <0.001 |
| MEAN | −89.57 [−94.33, −86.09] |
−80.75 [−85.76, −74.25] |
−84.31 [−87.72, −77.39] |
−78.04 [−82.49, −69.70] |
−73.77 [−79.98, −65.59] |
−80.75 [−85.56, −75.16] |
−72.05 [−77.50, −66] |
−84.15 [−86.99, −79.28] |
<0.001 | <0.001 | <0.001 | 0.004 | <0.001 |
| MEDIAN | −88.07±5.95 | −76.04±8.28 | −78.83±7.33 | −72.88±8.23 | −69.88±7.96 | −76.12±7.36 | −67.66±6.17 | −79.58±6.27 | <0.001 | <0.001 | <0.001 | 0.004 | <0.001 |
Data are presented as median [25%, 75%] or mean ± SD. FAI, fat attenuation index; TAK, Takayasu arteritis; CAI, coronary artery involvement.